Lineage Foundation for Good Celebrates One-Year Anniversary, Announces “Holidays for Good” Campaign
Lineage Foundation for Good (the “Foundation”), the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”), recently celebrated its one-year anniversary. The nonprofit, which aims to redirect food that would otherwise go to waste and address hunger to support the social and economic mobility of our communities, has successfully donated the equivalent of 239 million meals over the past two years.
“Given recent events, global hunger and food insecurity is rising, affecting more than 800 million people,” said Christine Rees-Zecha, Board President of the Lineage Foundation for Good. “Through the Lineage Foundation for Good, we aim to leverage our network, expertise, and partnerships to prevent waste and redirect food into the communities that need it most. While there is still more work to do, I am proud of the accomplishments we achieved in the first year, including delivering more than 200 million meals to those in need, made possible by our dedicated team members.”
Last October, Lineage launched the Lineage Foundation for Good following the Company’s successful inaugural campaign, which provided 100 million meals to people in need during the height of the pandemic. In addition to supporting Lineage’s philanthropic efforts, the Foundation has sought to strengthen initiatives and organizations that align with the Company’s mission to create innovative and sustainable solutions to help reduce food waste and fight food insecurity.
At its inception, the Foundation set a goal to donate the equivalent of 500 million meals to people in need by 2025. To date, it is on track to significantly exceed this goal. As the Foundation continues to make progress on this commitment, it has also achieved notable progress in the following areas:
- Raised over $234,000 to support the Global FoodBanking Network and the Polish Humanitarian Action Organization’s efforts in response to the ongoing conflict in Ukraine.
- Supported Lineage team members and their families impacted by the conflict who returned to Ukraine to assist by continuing to pay their wages, as well as providing stipends to team members who are housing refugees and covered the relocation costs of five families.
- Contributed over 1,000 volunteer hours in communities worldwide, such as volunteering at food banks and distributing meals at community-based kitchens.
- Issued more than $1.6 million in community-based grants to local food banks, schools and other community-based organizations to help with operational costs.
- Donated over $600,000 to the Team Member Hardship Grant program, an initiative dedicated to financially supporting Lineage team members through times of hardship.
- In partnership with Penske, Darden Foundation, supported the donation of 10 refrigerated trucks to Feeding America® member food banks.
- Received a historic one-million-pound donation that will benefit six food banks within the Feeding America network.
- Grew its global network of partnerships to 50 strategic partners, which includes the Global FoodBanking Network, Feeding America, Empowerment Plan, Move for Hunger and the Darden Foundation. Through these partnerships, the Foundation has coordinated volunteer events and made charitable donations to partners.
“Over the past year, we’ve partnered with the Lineage Foundation for Good on their mission to reduce food waste and address food insecurity,” said Diane Letson, vice president of food industry partnerships at Feeding America. “With nearly 34 million people facing hunger in America, and amid the challenging inflationary environment many are experiencing, we are grateful for the recent work that Lineage and its partners accomplished in diverting one million pounds of food from going to waste and ensuring that it reached our neighbors in need.”
Building on the momentum of a successful first year, the Foundation is also launching the “Holidays for Good” Campaign to donate food to local communities during the holiday season. Beginning in November and running through the holiday season, “Holidays for Good” will contribute the equivalent of one million meals through customer product donations, food drives and volunteer events that benefit local community food banks.
For more information on the Lineage Foundation for Good, visit the Foundation page here. You can also reach out to foundation@lineagelogistics.com for information on partnership opportunities, volunteer events, and other ways to support.
About Lineage Foundation for Good
The Lineage Foundation for Good (the “Foundation”) is the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”). The Foundation leverages the unique access, influence, experience, and expertise of Lineage, one of the world’s largest temperature-controlled logistics solutions providers, and its customers and partners to reduce food waste and fight food insecurity – a need that was accelerated by the practical challenges of getting quality food to those in need during the COVID-19 pandemic. Central to the Foundation’s mission is to develop a dynamic, real-time, and global link between those who commercially produce our food and the individuals, families, and communities who need it most. The Foundation creates a system in which food products, including those that might have otherwise gone to waste, can be quickly and easily steered to food pantries and other non-profits combatting food insecurity around the world. The Foundation supports various philanthropic initiatives that have an impact in the communities in which we live and work, and is proud to partner with Feeding America, the Global FoodBanking Network, and other organizations to expand its reach, maximize its impact, and help feed the world.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity, which spans 20 countries across North America, Europe, and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network and the development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was a 2022 U.S. Best Managed Company, No. 3 in the 2022 CNBC Disruptor 50 list, No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005327/en/
Contact information
Lineage Logistics
Christina Wiese
734-608-1855
cwiese@lineagelogistics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
